FRT vs UTMD · rev $1.28B vs P/E 15, rev $17.3M
FRT (FRT) versus Utah Medical Products Inc (UTMD) — a side-by-side from cached financials, not a winner call.
FRT (FRT) common stock.
Utah Medical Products Inc (UTMD) is a medical instruments & supplies company listed on US.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
Latest reported UTMD revenue for 2026-06-30 was $17.3M. Net income was $5.3M. Revenue was up 97.8% from 2026-03-31 to 2026-06-30. UTMD currently screens at market cap $189.8M and trailing P/E 15.4.
FRT currently screens at market cap $0. UTMD currently screens at market cap $189.8M and trailing P/E 15.4.
Not investment advice. Open the FRT and UTMD stock pages for the full models.
Not investment advice.